New York’s New Biomarker Testing Insurance Coverage: Your Rights Explained

A molecular bridge connecting a financial symbol (or insurance card) to a precisely focused biomarker icon and a patient silhouette, illustrating the successful legislative efforts to expand insurance coverage for biomarker testing, paving the way for personalized medicine.

Improvements to New York Health Insurance: Biomarker Testing Testing for biomarkers in patients is the state of the art in assessing the effectiveness of therapies. These tests enable healthcare providers to gain a deeper understanding of a patient’s disease and predict their response to treatment, making them a crucial tool in personalized medicine. New York […]

FDA Investigational Device Exemption (IDE) Process:
Requirements & Application Guide

Futuristic pacemaker in clinical setting symbolizing FDA IDE process

Demystifying the FDA Investigational Device Exemption (IDE) Process The journey to bring a new medical device to market is a complex regulatory gauntlet. For innovators and startups, one of the most critical and often misunderstood steps is securing an Investigational Device Exemption (IDE). An IDE is not a marketing clearance. It is a regulatory permission from […]

FDA IND Process Guide:
Legal Guidance & Common Mistakes

Legal document with approved stamp on wooden desk symbolizing FDA IND application review and regulatory approval process

Why the IND Process Matters  Drug sponsors face a long and winding road from discovery to market. A critical step on this journey is the investigational new drug application (IND). This is the official process where a sponsor must get approval from the Food and Drug Administration (FDA) to begin clinical research on human subjects. […]

Subscribe to Our Newsletter